ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Post-transplant malignancy"

  • 2020 American Transplant Congress

    Performance of the Retreat Score in Predicting Post-Transplant Hepatocellular Carcinoma Recurrence at a Large Academic Center

    N. Mahmud, N. Philips, S. Ekpanyapong, S. Prenner, M. Levine, R. Reddy, M. Hoteit

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: Post-transplant hepatocellular carcinoma recurrence (R-HCC) results in poor outcomes. The RETREAT score was recently derived to predict HCC recurrence, incorporating pre-transplant alpha fetoprotein and…
  • 2020 American Transplant Congress

    Transmission of Synovial Sarcoma by a Single Multiorgan Donor to Three Solid Organ Transplant Recipients

    J. Zhang, J. Lin, Y. Tian

    Beijing Friendship Hospital, Capital Medical University, Beijing, China

    *Purpose: To report 3 cases of donor-derived synovial sarcoma (SS) by a single multiorgan donor in China.*Methods: SS was diagnosed by the presence of SS18…
  • 2020 American Transplant Congress

    Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

    S. J. Yusuf1, H. Bheemreddy1, A. Imtiaz2, N. Krishnan3

    1Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, 2Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, 3Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

    *Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…
  • 2020 American Transplant Congress

    Contrary to Expectation, the Use of Immune Checkpoint Inhibitors is Not Consistently Associated with Early Onset Allograft Rejection in Solid Organ Transplant Recipients

    I. Owoyemi1, C. M. Costello2, C. Thongprayoon1, S. Markovic3, H. Joerg4, C. C. Otley5, T. Taner6, A. R. Mangold2, N. Leung1, S. Herrmann1, A. Kukla1

    1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 2Department of Dermatology, Mayo Clinic, Scottsdale, AZ, 3Division of Medical Oncology, Mayo Clinic, Rochester, MN, 4Department of Cardiology, Mayo Clinic, Rochester, MN, 5Department of Dermatology, Mayo Clinic, Rochester, MN, 6Departments of Surgery & Immunology, Mayo Clinic, Rochester, MN

    *Purpose: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are generally avoided in solid organ transplant recipients (SOTRs) due to concern for allograft rejection…
  • 2020 American Transplant Congress

    Tumor of Transplanted Kidney: Graft Resection Preserves Renal Function with Good Long-Term Oncologic Outcome

    J. Chlupac, T. Marada, M. Kudla, L. Janousek, J. Fronek

    Transplantation Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Incidence of urologic tumors is increased in renal transplant recipients. In case of a kidney transplant neoplasm, the graft-nephrectomy and hemodialysis reduce the quality…
  • 2020 American Transplant Congress

    De Novo Malignancy after Liver Transplantation for Alcoholic Cirrhosis: Incidence and Outcomes

    M. M. Pascale, E. Nure, G. Bianco, F. Frongillo, S. Agnes

    Transplant Unit, Fondazione "Policlinico A. Gemelli" UCSC - Rome, Roma, Italy

    *Purpose: De novo malignancy, frequent liver transplant (LT) complication, is one of the long-term major causes of mortality. Risk factors are related to immunosuppressive status,…
  • 2020 American Transplant Congress

    Short Tandem Repeat (STR) Analysis Identifies a Cancer Transmitted from an Organ Donor to 4 Transplant Recipients

    M. Park1, J. Van Ziffle1, E. Collisson1, J. Grenert1, S. Behr1, A. Gonzalez1, J. Chou1, S. Maisel1, T. Friedlander1, C. Freise1, J. Shoji1, T. Semrad2, P. Chin-Hong1, C. Atreya1

    1UCSF, San Francisco, CA, 2Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA

    *Purpose: Organ donors are systematically screened for infection, while screening for malignancy is less rigorous. The true incidence of donor-transmitted malignancies is unknown due to…
  • 2020 American Transplant Congress

    Management of Pancreatic Cancer after Liver Transplantation: A 27-Year Single-Center Experience

    I. A. Ziogas, M. A. Rauf, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. P. Alexopoulos

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: The occurrence of de novo cancer after liver transplant (LT) is a leading cause of post-LT mortality and can be partially attributed to the…
  • 2019 American Transplant Congress

    Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis

    A. Chewcharat1, C. Thongprayoon2, B. Boonpheng3, A. Torres-Ortiz4, M. A Mao2, N. J Khoury5, W. Cheungpasitporn4

    1Harvard T.H. Chan, Boston, MA, 2Mayo Clinic, Rochester, MN, 3East Tennessee State University, Johnson City, TN, 4University of Mississippi Medical Center, Jackson, MS, 5Henry Ford Hospital, Detroit, MI

    *Purpose: The incidence and mortality of renal cell carcinoma (RCC) after kidney transplantation (KTx) remain unclear. This study's aims were 1) to investigate the pooled…
  • 2019 American Transplant Congress

    Lower Incidence of Posttransplant Malignancies under Vitamin D (Calcidiol) Treatment in Kidney Transplantation

    I. Revuelta1, V. Tubita2, J. Ugalde1, D. Cucchiari1, F. Oppenheimer1, F. Diekmann1, J. Campistol1, J. Torregrosa1

    1Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, 2Experimental Laboratory of Nephrology and Kidney Transplant, IDIBAPS, Barcelona, Spain

    *Purpose: An increasing body of evidence has emerged on the role of 1α,25-dihydroxyvitamin D3[1,25(OH) 2 D] in cell differentiation, which seems to have regulation properties…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences